Richard A Miller Md bought $45k of CRVS
President and CEO at Corvus Pharmaceuticals, Inc.. 60,000 shares at an average of $0.75, traded Dec 13, 2022, filed Dec 15, 2022.
Score components
- +25RoleCEO
- +6Trade size$45k at market
- 0Relative to holdingsHoldings up 4.2%
- +18Price context9% above the 52-week low; 74% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001567619-22-021650, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 13, 2022 | POpen-market purchase Common Stockindirect: By Trust | +50,000 | $0.74 | $37k | 1,480,119 | Dec 15, 2022 |
| Dec 14, 2022 | POpen-market purchase Common Stockindirect: By Trust | +10,000 | $0.78 | $7,812 | 1,490,119 | Dec 15, 2022 |
Related signals
Other insiders at Corvus Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 44Moderate | CRVSbuy Corvus Pharmaceuticals, Inc. | David Scott Moore director | $250k 21,700 shares | - | |
| 37Weak | CRVSbuy Corvus Pharmaceuticals, Inc. | Richard A Miller Md President and CEO | $83k 6,932 shares | +1% | |
| 53Moderate | Corvus Pharmaceuticals, Inc. | Peter A. Thompson director, owner | $4.9M 1,176,332 shares | -14% | |
| 53Moderate | Corvus Pharmaceuticals, Inc. | Orbimed Advisors LLC director, owner | $4.9M 1,176,332 shares | -14% | |
| 74Notable | Corvus Pharmaceuticals, Inc. | Richard A Miller Md President and CEO | $1000k 577,634 shares | - | |
| 40Moderate | Corvus Pharmaceuticals, Inc. | William Benton Jones See Remarks | $35k 20,000 shares | +15% | |
| 41Moderate | Corvus Pharmaceuticals, Inc. | William Benton Jones See Remarks | $16k 20,000 shares | +18% | |
| 66Notable | Corvus Pharmaceuticals, Inc. | Leiv Lea Chief Financial Officer | $26k 34,000 shares | +34% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.